PCCN-Toronto is a group of prostate cancer survivors (which includes partners) who volunteer to provide support to men, from the newly diagnosed to long-term survivors, and their partners and families.
Articles from the Internet are regularly gleaned from the website and posted. An attempt is made to categorize them, as listed in the sidebar on the right. Click on the Categories widget to see the categories, and select the category of interest. They will appear on a new page in order from the most recent to the oldest. Some are from refereed scientific journals, while other are from more popular press websites. Almost all posts include a very brief description with a link to the actual article. As always, be careful about the source.
It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks.
Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease.
All men should be screened for prostate cancer, at some point, but those who are most at risk for the condition might no longer need a biopsy and surgery under brand new guidelines from the National Institutes of Health and Care Excellence.
Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of disease and likelihood of recurrence, according to study results.